All Pharma News
price-trendAsk Us
Ubiquigent and Debiopharm team up to advance USP1 inhibitor

Ubiquigent and Debiopharm team up to advance USP1 inhibitor
Jenna Philpott PHARMACEUTICAL TECHNOLOGY
27 Mar 2024
Share Share
Ubiquigent and Debiopharm Enter Agreement to Support for Debio 0432

Ubiquigent and Debiopharm Enter Agreement to Support for Debio 0432
BUSINESSWIRE
26 Mar 2024
Share Share
Ubiquigent Enters Agreement With Astellas Subsidiary, Nanna Therapeutics

Ubiquigent Enters Agreement With Astellas Subsidiary, Nanna Therapeutics
BUSINESSWIRE
11 Mar 2024
Share Share
Ubiquigent DUB inhibitor pact survives Bristol-Celgene merger

Ubiquigent DUB inhibitor pact survives Bristol-Celgene merger
 Nick Paul Taylor FIERCE BIOTECH
19 Jun 2020
Share Share
Avidity tops up IPO at $298M; Bristol Myers keeps a Celgene discovery pact alive

Avidity tops up IPO at $298M; Bristol Myers keeps a Celgene discovery pact alive
ENDPTS
17 Jun 2020
Share Share
Ubiquigent Continues Drug Discovery Collaboration With Bristol Myers Squibb

Ubiquigent Continues Drug Discovery Collaboration With Bristol Myers Squibb
BUSINESSWIRE
17 Jun 2020
Share Share